193 related articles for article (PubMed ID: 35805106)
1. Microglial Depletion Has No Impact on Disease Progression in a Mouse Model of Machado-Joseph Disease.
Campos AB; Duarte-Silva S; Fernandes B; Coimbra B; Campos J; Monteiro-Fernandes D; Teixeira-Castro A; Ambrósio AF; Maciel P
Cells; 2022 Jun; 11(13):. PubMed ID: 35805106
[TBL] [Abstract][Full Text] [Related]
2. Profiling Microglia in a Mouse Model of Machado-Joseph Disease.
Campos AB; Duarte-Silva S; Fernandes B; das Neves SP; Marques F; Teixeira-Castro A; Neves-Carvalho A; Monteiro-Fernandes D; Portugal CC; Socodato R; Summavielle T; Ambrósio AF; Relvas JB; Maciel P
Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203447
[TBL] [Abstract][Full Text] [Related]
3. Chronic treatment with 17-DMAG improves balance and coordination in a new mouse model of Machado-Joseph disease.
Silva-Fernandes A; Duarte-Silva S; Neves-Carvalho A; Amorim M; Soares-Cunha C; Oliveira P; Thirstrup K; Teixeira-Castro A; Maciel P
Neurotherapeutics; 2014 Apr; 11(2):433-49. PubMed ID: 24477711
[TBL] [Abstract][Full Text] [Related]
4. Machado Joseph disease severity is linked with gut microbiota alterations in transgenic mice.
Gamage HKAH; Robinson KJ; Luu L; Paulsen IT; Laird AS
Neurobiol Dis; 2023 Apr; 179():106051. PubMed ID: 36822548
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective Effects of Creatine in the CMVMJD135 Mouse Model of Spinocerebellar Ataxia Type 3.
Duarte-Silva S; Neves-Carvalho A; Soares-Cunha C; Silva JM; Teixeira-Castro A; Vieira R; Silva-Fernandes A; Maciel P
Mov Disord; 2018 May; 33(5):815-826. PubMed ID: 29570846
[TBL] [Abstract][Full Text] [Related]
6. Calpain Inhibition Is Protective in Machado-Joseph Disease Zebrafish Due to Induction of Autophagy.
Watchon M; Yuan KC; Mackovski N; Svahn AJ; Cole NJ; Goldsbury C; Rinkwitz S; Becker TS; Nicholson GA; Laird AS
J Neurosci; 2017 Aug; 37(32):7782-7794. PubMed ID: 28687604
[TBL] [Abstract][Full Text] [Related]
7. The autophagy-enhancing drug carbamazepine improves neuropathology and motor impairment in mouse models of Machado-Joseph disease.
Vasconcelos-Ferreira A; Carmo-Silva S; Codêsso JM; Silva P; Martinez ARM; França MC; Nóbrega C; Pereira de Almeida L
Neuropathol Appl Neurobiol; 2022 Feb; 48(1):e12763. PubMed ID: 34432315
[TBL] [Abstract][Full Text] [Related]
8. Silencing mutant ataxin-3 rescues motor deficits and neuropathology in Machado-Joseph disease transgenic mice.
Nóbrega C; Nascimento-Ferreira I; Onofre I; Albuquerque D; Hirai H; Déglon N; de Almeida LP
PLoS One; 2013; 8(1):e52396. PubMed ID: 23349684
[TBL] [Abstract][Full Text] [Related]
9. Genetic Ablation of Inositol 1,4,5-Trisphosphate Receptor Type 2 (IP
Cunha-Garcia D; Monteiro-Fernandes D; Correia JS; Neves-Carvalho A; Vilaça-Ferreira AC; Guerra-Gomes S; Viana JF; Oliveira JF; Teixeira-Castro A; Maciel P; Duarte-Silva S
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445783
[TBL] [Abstract][Full Text] [Related]
10. RNA Interference Therapy for Machado-Joseph Disease: Long-Term Safety Profile of Lentiviral Vectors Encoding Short Hairpin RNAs Targeting Mutant Ataxin-3.
Nóbrega C; Codêsso JM; Mendonça L; Pereira de Almeida L
Hum Gene Ther; 2019 Jul; 30(7):841-854. PubMed ID: 30760052
[TBL] [Abstract][Full Text] [Related]
11. Trehalose alleviates the phenotype of Machado-Joseph disease mouse models.
Santana MM; Paixão S; Cunha-Santos J; Silva TP; Trevino-Garcia A; Gaspar LS; Nóbrega C; Nobre RJ; Cavadas C; Greif H; Pereira de Almeida L
J Transl Med; 2020 Apr; 18(1):161. PubMed ID: 32272938
[TBL] [Abstract][Full Text] [Related]
12. Limited Effect of Chronic Valproic Acid Treatment in a Mouse Model of Machado-Joseph Disease.
Esteves S; Duarte-Silva S; Naia L; Neves-Carvalho A; Teixeira-Castro A; Rego AC; Silva-Fernandes A; Maciel P
PLoS One; 2015; 10(10):e0141610. PubMed ID: 26505994
[TBL] [Abstract][Full Text] [Related]
13. Preclinical Evidence Supporting Early Initiation of Citalopram Treatment in Machado-Joseph Disease.
Esteves S; Oliveira S; Duarte-Silva S; Cunha-Garcia D; Teixeira-Castro A; Maciel P
Mol Neurobiol; 2019 May; 56(5):3626-3637. PubMed ID: 30173407
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of mutant ataxin-3 in mouse cerebellum induces ataxia and cerebellar neuropathology.
Nóbrega C; Nascimento-Ferreira I; Onofre I; Albuquerque D; Conceição M; Déglon N; de Almeida LP
Cerebellum; 2013 Aug; 12(4):441-55. PubMed ID: 23242710
[TBL] [Abstract][Full Text] [Related]
15. A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD.
Switonski PM; Szlachcic WJ; Krzyzosiak WJ; Figiel M
Neurobiol Dis; 2015 Jan; 73():174-88. PubMed ID: 25301414
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiological interplay between
Pereira Sena P; Weber JJ; Watchon M; Robinson KJ; Wassouf Z; Hauser S; Helm J; Abeditashi M; Schmidt J; Hübener-Schmid J; Schöls L; Laird AS; Riess O; Schmidt T
Proc Natl Acad Sci U S A; 2021 Nov; 118(47):. PubMed ID: 34785590
[TBL] [Abstract][Full Text] [Related]
17. Motor uncoordination and neuropathology in a transgenic mouse model of Machado-Joseph disease lacking intranuclear inclusions and ataxin-3 cleavage products.
Silva-Fernandes A; Costa Mdo C; Duarte-Silva S; Oliveira P; Botelho CM; Martins L; Mariz JA; Ferreira T; Ribeiro F; Correia-Neves M; Costa C; Maciel P
Neurobiol Dis; 2010 Oct; 40(1):163-76. PubMed ID: 20510362
[TBL] [Abstract][Full Text] [Related]
18. The blood-brain barrier is disrupted in Machado-Joseph disease/spinocerebellar ataxia type 3: evidence from transgenic mice and human post-mortem samples.
Duarte Lobo D; Nobre RJ; Oliveira Miranda C; Pereira D; Castelhano J; Sereno J; Koeppen A; Castelo-Branco M; Pereira de Almeida L
Acta Neuropathol Commun; 2020 Aug; 8(1):152. PubMed ID: 32867861
[TBL] [Abstract][Full Text] [Related]
19. Unravelling Endogenous MicroRNA System Dysfunction as a New Pathophysiological Mechanism in Machado-Joseph Disease.
Carmona V; Cunha-Santos J; Onofre I; Simões AT; Vijayakumar U; Davidson BL; Pereira de Almeida L
Mol Ther; 2017 Apr; 25(4):1038-1055. PubMed ID: 28236575
[TBL] [Abstract][Full Text] [Related]
20. Silencing ataxin-3 mitigates degeneration in a rat model of Machado-Joseph disease: no role for wild-type ataxin-3?
Alves S; Nascimento-Ferreira I; Dufour N; Hassig R; Auregan G; Nóbrega C; Brouillet E; Hantraye P; Pedroso de Lima MC; Déglon N; de Almeida LP
Hum Mol Genet; 2010 Jun; 19(12):2380-94. PubMed ID: 20308049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
